Nolvadex-D TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: tamoxifen
Pack: Nolvadex-D 20 mg tablet, 30, blister pack
Brand name
(ARTG)
: NOLVADEX-D Tamoxifen 20mg (as citrate) tablet blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Treatment of breast cancer NOLVADEX-D is indicated for the treatment of breast cancer. Primary reduction of breast cancer risk NOLVADEX-D is indicated for the primary reduction of breast cancer risk in women either at moderately increased risk (lifetime breast cancer risk 1.5 to 3 times the population average) or high risk (lifetime breast cancer risk greater than 3 times the population average).
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, film coated
- Oral
- white to off white, biconvex, octagonal, film coated tablets (marked NOLVADEX-D)
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Protect from Light
- Shelf lifetime is 5 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 10 tablets (sample) pack
- 30 tablets pack
- 30 tablets (hospital pack) pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient tamoxifen
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
